Modifiable Risk Factors Associated With Moyamoya Disease A Case-Control Study
Modifiable Risk Factors Associated With Moyamoya Disease A Case-Control Study
复制标题
与烟雾病相关的可改变危险因素病例对照研究
DOI:
10.1161/strokeaha.120.030027
复制
发表时间:
2020-08-01
期刊:
影响因子:
8.3
通讯作者:
Zhao, Jizong
中科院分区:
文献类型:
--
作者:
Ge, Peicong;Zhang, Qian;Zhao, Jizong
Background and Purpose: The cause of moyamoya disease (MMD) remains unknown. We aimed to investigate the association between modifiable risk factors and MMD in a prospective, case-control study.Methods: Clinical and laboratory characteristics were evaluated in consecutively recruited adult patients with MMD and age-matched healthy control individuals. The potential risk factors for MMD were estimated by logistic regression analysis.Results: Our prospective study included 138 adult patients and 138 healthy control subjects. Logistic regression analyses showed that increased body mass index (odds ratio [OR], 1.121 [95% CI, 1.018-1.234];P=0.020) and homocysteine (OR, 1.201 [95% CI, 1.081-1.334];P=0.001) were associated with higher risk of MMD. Whereas increased albumin (OR, 1.043 [95% CI, 1.004-1.082];P=0.028) and high-density lipoprotein cholesterol (OR, 1.043 [95% CI, 1.004-1.082];P=0.028) were correlated with a lower risk of MMD. Furthermore, homocysteine (OR, 1.070 [95% CI, 1.010-1.134];P=0.023) was significantly related to unilateral lesions.Conclusions: Increased body mass index and homocysteine were associated with a higher risk of MMD. In contrast, increased albumin and high-density lipoprotein cholesterol were correlated with a lower risk of MMD. Furthermore, increased homocysteine was related to a higher prevalence of unilateral MMD. More attention should be paid to the modifiable risk factors of MMD, as these might help us finding its cause and new therapeutic regimen.